José Cabeza-Barrera (José Cabeza, Jose Cabeza-Barrera)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Intensive Care Unit

Ejection Fraction

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón-García, José Cabeza-Barrera, Antonio Luis Medina-Castillo, Raquel Pérez-Robles, Natalia Navas
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate. Vaccines 11 (11) (2023)
Jorge G García, Patricia Diez-Echave, María Eugenia Yuste, Natalia Chueca, Federico Garcia, José Cabeza-Barrera, Emilio Fernández-Varón, Julio Juan Gálvez Peralta, Manuel Colmenero, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Rocío Morón
Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Jorge G García, Patricia Diez-Echave, María Eugenia Yuste, Natalia Chueca, Federico Garcia, José Cabeza-Barrera, Emilio Fernández-Varón, Julio Juan Gálvez Peralta, Manuel Colmenero, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Rocío Morón
Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Anabel Torrente-López, Jesús Hermosilla, Antonio Salmerón-García, José Cabeza-Barrera, Natalia Navas
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. Pharmaceutics 14 (4) (2022)
Anabel Torrente-López, Jesús Hermosilla, Natalia Navas, Luis Cuadros-Rodríguez, José Cabeza-Barrera, Antonio Salmerón-García
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines 9 (6) (2021)